Oruka Therapeutics, Inc.
ORKA • XNAS
Oruka Therapeutics, Inc. is a in vitro & in vivo diagnostic substances company trading on XNAS, led by CEO Lawrence Otto Klein, with a market cap of $2.2B.
CEOLawrence Otto Klein
Market Cap$2.2B
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Next Earnings
Upcoming earnings announcement for Oruka Therapeutics, Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.52
Earnings History
Past 6 earnings reports for Oruka Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | -$0.45Est: -$0.61 | +26.2% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.55Est: -$0.54 | -1.9% | - | — | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$0.46Est: -$0.45 | -2.2% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.40Est: -$0.49 | +18.4% | - | — | 10-Q |
| Mar 6, 2025 | Q4 2024 | -$0.49Est: -$0.98 | +50.0% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$1.46Est: -$0.40 | -265.0% | - | — | 10-Q |